Author:
Tauzin Alexandra,Marchitto Lorie,Bélanger Étienne,Benlarbi Mehdi,Beaudoin-Bussières Guillaume,Prévost Jérémie,Yang Derek,Chiu Ta-Jung,Chen Hung-Ching,Bourassa Catherine,Medjahed Halima,Korzeniowski Marek K,Gottumukkala Suneetha,Tolbert William D.,Richard Jonathan,Smith Amos B,Pazgier Marzena,Finzi Andrés
Abstract
ABSTRACTCD4-mimetics (CD4mcs) are small molecule compounds that mimic the interaction of the CD4 receptor with HIV-1 envelope glycoproteins (Env). Env from primary viruses normally samples a “closed” conformation which occludes epitopes recognized by CD4-induced (CD4i) non-neutralizing antibodies (nnAbs). CD4mcs induce conformational changes on Env resulting in the exposure of these otherwise inaccessible epitopes. Here we evaluated the capacity of plasma from a cohort of 50 people living with HIV to recognize HIV-1-infected cells and eliminate them by antibody-dependent cellular cytotoxicity (ADCC) in the presence of a potent indoline CD4mc. We observed a marked heterogeneity among plasma samples. By measuring the levels of different families of CD4i Abs, we found that the levels of anti-cluster A, anti-coreceptor binding site and anti-gp41 cluster I antibodies are responsible for plasma-mediated ADCC in presence of CD4mc.IMPORTANCEThere are several reasons that make it difficult to target the HIV reservoir. One of them, is the capacity of infected cells to prevent the recognition of HIV-1 envelope glycoproteins (Env) by commonly-elicited antibodies in people living with HIV. Small CD4-mimetic compounds expose otherwise occluded Env epitopes, thus enabling their recognition by non-neutralizing antibodies. A better understanding of the contribution of these antibodies to eliminate infected cells in presence of CD4mc could lead to the development of therapeutic cure strategies.
Publisher
Cold Spring Harbor Laboratory